BAIN CAPITAL INVESTORS LLC Q2 2022 holdings

$4.78 Billion is the total value of BAIN CAPITAL INVESTORS LLC's 5 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .

 Value Shares↓ Weighting
CERE  CEREVEL THERAPEUTICS HLDNG I$1,603,119
-24.5%
60,632,3560.0%33.55%
+9.2%
DSEY  DIVERSEY HLDGS LTD$1,561,304
-12.8%
236,561,1590.0%32.67%
+26.1%
SGRY  SURGERY PARTNERS INC$1,418,948
-47.5%
49,064,5760.0%29.69%
-24.0%
AVAH  AVEANNA HEALTHCARE HLDGS INC$184,418
-33.7%
81,600,8800.0%3.86%
-4.1%
ADV  ADVANTAGE SOLUTIONS INC$10,982
-40.4%
2,890,0000.0%0.23%
-13.9%

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Bain Capital Integral Investors 2008, L.P. #1
  • Bain Capital Integral Investors 2006, LLC #2
  • BCPE Seminole GP LLC #3
  • BCPE Seminole Holdings LP #4
  • Bain Capital Partners XII, LLC #5
  • Bain Capital Fund XII, L.P. #6
  • BCPE Perception GP, LLC #7
  • BC Perception Holdings, LP #8
  • Bain Capital Partners XI, L.P. #9
  • Bain Capital Fund XI, L.P. #10
  • BCPE Eagle GP, LLC #11
  • BCPE Diamond GP, LLC #12
  • BCPE Eagle Investor, LP #13
  • BCPE Diamond Investor, LP #14
  • Bain Capital Partners Europe IV, L.P. #15
  • Bain Capital Europe Fund IV, L.P. #16
  • BCPE Diamond Cayman Holding Ltd #17
  • BCIP Associates IV, L.P. #18
  • BCIP Associates IV (US), L.P. #19

The following EDGAR filing(s) were analyzed to create this report:

The EDGAR filing(s) were signed by:

  • Michael D. Ward — Managing Director of Bain Capital Investors, LLC

Compare quarterly holdings

Export BAIN CAPITAL INVESTORS LLC's holdings

EDGAR filings